Search Press releases Keywords From To 30 May 2023 UCB Showcases Commitment to Advancing Care in Immune-Mediated Inflammatory Diseases with 23 Abstracts at EULAR 2023 Read More 26 May 2023 Transparency notification FMR LLC Read More 23 May 2023 UCB and Veeva collaborate to advance the patient experience in clinical trials Read More 11 May 2023 UCB and Ariceum Therapeutics sign a Strategic Research Collaboration to Discover New Modalities for the Treatment of Immune-related Diseases and Cancer Read More 27 Apr 2023 UCB’s General Meeting of Shareholders 2023 Read More 27 Apr 2023 UCB Receives Positive CHMP Opinions for Bimekizumab for the Treatment of Adults with Psoriatic Arthritis and Axial Spondyloarthritis in the European Union Read More Pagination First page Previous page Previous … Page 25 Page 26 Page 27 Page 28 Current page 29 Page 30 Page 31 Page 32 Page 33 … Page 29 of 59 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
